NCT04460586CompletedPhase 4
Pharmacokinetics of Omadacycline in Cystic Fibrosis
Pharmacokinetics of Omadacycline in Patients With Cystic Fibrosis
Source: ClinicalTrials.gov · Last updated 8 May 2026
Brief summary (registry, in English)
The purpose of this study is to characterize the pharmacokinetics of intravenous and oral omadacycline in patients with cystic fibrosis.
- Status (registry)
- Completed
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 9 (actual)
- First submitted
- 1 Jul 2020
- Start date
- 1 Jul 2021
- Primary completion date
- 1 Dec 2023
- Lead sponsor
- Paul Beringer
- Diseases
- Cystic fibrosis
- NCT number
- NCT04460586
What you commit to
- Study type: Interventional · Phase 4
- Participants enrolled: 9
- From 1 Jul 2021 to the primary completion date, 1 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Serious past allergy to a tetracycline antibiotic
Lab values
- Hemoglobin \< 8 g/dL
Other
- Presence of an ongoing acute pulmonary exacerbation defined based on clinical signs \& symptoms and an acute decline in relative FEV1 of 10% or greater.
- Pregnancy or breastfeeding
- No alcohol, nicotine, or caffeine-containing products during the study period
Who the study is looking for
- Diagnosis of CF based on positive sweat chloride or known CF mutation
- Age \>=18 years
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Southern California Coordinator of this site? Confirm its status | Los Angeles | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.